| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |